|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Goodwill impairment charge | |||||
| Amortization of intangibles | |||||
| Depreciation and amortization of premises and equipment | |||||
| Net accretion of discounts and amortization of premiums and deferred fees | |||||
| Interest capitalized on loans subject to the temporary payment moratorium or loss mitigation alternatives | |||||
| Share-based compensation | |||||
| Impairment losses on right-of-use and long-lived assets | |||||
| Fair value adjustments on mortgage servicing rights | |||||
| Fair value adjustment for contingent consideration | |||||
| Adjustments to indemnity reserves on loans sold | |||||
| Losses (earnings) from investments under the equity method, net of dividends or distributions | |||||
| Deferred income tax expense (benefit) | |||||
| (Gain) loss on: | |||||
| Disposition of premises and equipment and other productive assets | |||||
| Proceeds from insurance claims | |||||
| Sale of debt securities | |||||
| Sale of loans, including valuation adjustments on loans held-for-sale and mortgage banking activities | |||||
| Sale of equity method investment | |||||
| Sale of stock in equity method investee / as part of the Evertec Transactions | |||||
| Other equity method investees | |||||
| EVERTEC Assets | |||||
| Total sale of stock in equity method investee / as part of the Evertec Transactions | |||||
| Sale of foreclosed assets, including write-downs | |||||
| Acquisitions of loans held-for-sale | |||||
| Proceeds from sale of loans held-for-sale | |||||
| Net originations on loans held-for-sale | |||||
| Net decrease (increase) in: | |||||
| Trading debt securities | |||||
| Equity securities | |||||
| Accrued income receivable | |||||
| Other assets | |||||
| Net increase (decrease) in: | |||||
| Interest payable | |||||
| Pension and other postretirement benefits obligation | |||||
| Other liabilities | |||||
| Total adjustments | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Net decrease (increase) in money market investments | |||||
| Purchases of investment securities: | |||||
| Available-for-sale | |||||
| Held-to-maturity | |||||
| Equity | |||||
| Proceeds from calls, paydowns, maturities and redemptions of investment securities: | |||||
| Available-for-sale | |||||
| Held-to-maturity | |||||
| Proceeds from sale of investment securities: | |||||
| Available-for-sale | |||||
| Equity | |||||
| Net disbursements on loans | |||||
| Proceeds from sale of loans | |||||
| Acquisition of loan portfolios | |||||
| Payments to acquire other intangible | |||||
| Payments to acquire businesses, net of cash acquired | |||||
| Return of capital from equity method investments | |||||
| Payments to acquire equity method investments | |||||
| Proceeds from sale of equity method investment | |||||
| Other equity method investees | |||||
| EVERTEC Assets | |||||
| Total proceeds from sale of equity method investment | |||||
| Proceeds from sale of stock in equity method investee | |||||
| Proceeds from disposition of stock as part of the Evertec Transactions | |||||
| Acquisition of premises and equipment | |||||
| Proceeds from insurance claims | |||||
| Proceeds from sale of: | |||||
| Premises and equipment and other productive assets | |||||
| Foreclosed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in: | |||||
| Deposits | |||||
| Assets sold under agreements to repurchase | |||||
| Other short-term borrowings | |||||
| Payment of notes payable | |||||
| Principal payments of finance leases | |||||
| Proceeds from issuance of notes payable | |||||
| Proceeds from issuance of common stock | |||||
| Dividends paid | |||||
| Net payments for repurchase of common stock | |||||
| Payments related to tax witholding for share-based compensation | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash and due from banks, and restricted cash | |||||
| Cash and due from banks and restricted cash at beginning of period | |||||
| Cash and due from banks and restricted cash at end of period | |||||
Loading...